Evidence by drug
Metronomic vinorelbine
136 studies and 43 trials indexed. 7 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingPhase 1FranceNCT02897986Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid TumorsAssistance Publique Hopitaux De Marseille
- RecruitingPhase 1, Phase 2Denmark, France, Italy, and 3 moreNCT02813135European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsGustave Roussy, Cancer Campus, Grand Paris
- RecruitingPhase 2ChinaNCT06771609Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 2FranceNCT07001618Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung CancerGustave Roussy, Cancer Campus, Grand Paris
- RecruitingNot statedChinaNCT07041320Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung CancerAnhui Chest Hospital
- Not yet recruitingNot applicableNCT07589972Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast CancerTianjin Medical University Cancer Institute and Hospital
- Not yet recruitingPhase 2NCT06229067Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences
Newest studies
- StudyNeoplasma2026 OctAfatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.Yin C, et al.
- Systematic reviewCancer Treat Rev2026 SepVinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.Haveman LM, et al.
- ReviewCancers (Basel)2026 Aug 3Predictive Biomarkers of Metronomic Chemotherapy Response in Solid Tumors: Chasing an Elusive Signal.Wysocki PJ, et al.
- StudyJCO Precis Oncol2026 AugDPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.Schettini F, et al.
- StudyCancers (Basel)2026 Jul 17Adverse Events as a Surrogate of Sufficient Pharmacological Exposure in Metronomic Combination Chemotherapy: Extended Real-World Cohort Analysis of the FulVEC Regimen in Metastatic ER+/HER2- Breast Cancer.Buda-Nowak A, et al.
- StudyBMC Cancer2026 Jul 17Efficacy and safety of metronomic oral vinorelbine in elderly patients with locally advanced and metastatic non-small cell lung cancer.Soliman SH and Atef MM
- StudyPediatr Blood Cancer2026 JulSafety and Efficacy of Vinorelbine and Continuous Low-Dose Cyclophosphamide Chemotherapy in Japanese Pediatric Patients With Relapsed or Refractory Rhabdomyosarcoma.Yanai R, et al.
- ReviewTransl Cancer Res2026 Apr 30Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review.Li S, et al.
- StudySci Rep2026 Apr 6A real-world study of oral low-dose metronomic vinorelbine in elderly patients with metastatic triple-negative breast cancer.Li J, et al.
- StudyTransl Breast Cancer Res2026The efficacy and safety of metronomic vinorelbine combined with anlotinib in HER2-negative advanced breast cancer: a prospective, single-arm clinical study.Wang X, et al.
- StudyCancers (Basel)2026 Jan 22Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis.Pelliccia S, et al.
- StudyInt J Mol Sci2025 Dec 22Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids.Ilari A, et al.
- Clinical trialESMO Open2025 NovMOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.Borcoman E, et al.
- Clinical trialBreast2025 OctTremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study.De La Motte Rouge T, et al.
- Randomized trialBreast Cancer Res Treat2025 SepA direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.Brems-Eskildsen AS, et al.
- StudyInt J Clin Oncol2025 JunCorrection: The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis.Xu K, et al.
- StudySci Rep2025 Apr 3Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathway.Banchi M, et al.
- Clinical trialCancer Res Treat2025 AprCombination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study.Hao C, et al.
- StudyInvest New Drugs2025 FebLinifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathway.Banchi M, et al.
- Clinical trialJ Immunother Cancer2025 Jan 7Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study.Frenel JS, et al.
- StudyBMC Cancer2025 Jan 3Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study.Liu J, et al.
- StudyClin Transl Oncol2024 DecEfficacy and safety of metronomic oral vinorelbine and its combination therapy as second- and later-line regimens for advanced non-small-cell lung cancer: a retrospective analysis.Chen S, et al.
- ReviewChilds Nerv Syst2024 OctChemotherapy in pediatric low-grade gliomas (PLGG).Lassaletta A, et al.
- Randomized trialNat Med2024 SepMetronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.Mo H, et al.
- Randomized trialBreast2024 AprSingle-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.Freyer G, et al.
- StudyInt J Oncol2024 FebDual‑directional effect of vinorelbine combined with cisplatin or fluorouracil on tumor growth and metastasis in metronomic chemotherapy in breast cancer.Liu H, et al.
- StudyFundam Clin Pharmacol2024 FebDose-dependent bidirectional pharmacological effects of vinorelbine-based metronomic combination chemotherapy on tumor growth and metastasis and mechanisms in melanoma mouse model.Liu H, et al.
- Case reportChemotherapy2024Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report.Banchi M, et al.
- Randomized trialJAMA Oncol2023 Sep 1Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.Munzone E, et al.
- ReviewCancers (Basel)2023 Aug 7Maintenance Chemotherapy for Patients with Rhabdomyosarcoma.Bisogno G, et al.
- Clinical trialThorac Cancer2023 AugA phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer.Chai Y, et al.
- StudyFront Pharmacol2023Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study.Lan Y, et al.
- StudyBreast Care (Basel)2023 MayReal-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study.Krajnak S, et al.
- Clinical trialLung Cancer2023 AprSafety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).Vergnenegre A, et al.
- StudyJ Clin Med2023 Mar 27Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge.Orecchioni S, et al.
- Randomized trialBreast Cancer2023 MarCHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.Bailleux C, et al.
- StudyJ Clin Med2023 Feb 8Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data.Buda-Nowak A, et al.
- StudyEXCLI J2023Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells.Krajnak S, et al.
- StudyAnticancer Agents Med Chem2023Efficacy of Osimertinib Continuation Plus Metronomic Oral Vinorelbine for EGFRmutant Advanced NSCLC Beyond Limited Progression on Osimertinib.Li M, et al.
- StudyCancers (Basel)2022 Dec 9Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial.Camerini A, et al.
